Giuseppe Carota1, Lucia Di Pietro2,3, Vincenzo Cardaci4, Anna Privitera1,2, Francesco Bellia1, Valentina Di Pietro5, Giuseppe Lazzarino1, Barbara Tavazzi6, Angela Maria Amorini1, Giacomo Lazzarino6, Giuseppe Caruso6,7,*
BIOCELL, Vol.49, No.4, pp. 563-578, 2025, DOI:10.32604/biocell.2025.062176
- 30 April 2025
Abstract Carnosine (β-alanyl-L-histidine) is a naturally occurring endogenous peptide widely distributed in excitable tissues, such as the heart and brain. Over the years, several beneficial effects of carnosine have been discussed well in scientific literature. In particular, this dipeptide is well-known for its antioxidant, anti-inflammatory, and anti-aggregation activities. It is of great interest in the context of numerous systemic and neurodegenerative diseases, besides performing important “side activities” such as metal chelation and pH-buffering. Despite a plethora of preclinical and clinical data supporting carnosine’s therapeutic potential, researchers are still searching for new pharmacological targets that better highlight More >